Analysts: Merck Downgraded to Hold and 3 Other Research Notes to Look At

Merck (NYSE:MRK): Jefferies downgraded Merck to Hold from Buy, citing deteriorating base business fundamentals and a cost-cutting program that turned out to be more limited than initially expected. The firm lowered its price target for Merck shares to $50 from $53.

MRK 20131011

Micron (NASDAQ:MU): Wells Fargo downgraded Micron to Underperform from Market Perform, citing valuation following the company’s quarterly results. Wells also raised its earnings estimates for Micron and upped its price target range for the shares to $14-$17 from $11-$14, but notes its new valuation range is below the current share price. Shares of Micron closed yesterday up 28c to $18.43.

MU 20131011

Spirit Airlines (NASDAQ:SAVE): Citigroup upgraded Spirit Airlines to Buy from Neutral, citing the company’s strong September traffic statistics and a better-than-expected third-quarter revenue per available seat mile (RASM) guidance. The firm raised its price target for the shares to $42 from $38.

SAVE 20131011

AstraZeneca (NYSE:AZN): Jefferies downgraded AstraZeneca to Underperform from Hold, citing deteriorating base business fundamentals.

AZN 20131011

Investing Insights: Will An Upgrade Send T-Mobile Higher?